Case-8_Section-E_Group-4_Q3,4,5.docx - Submitted by Group 4...

This preview shows page 1 - 3 out of 5 pages.

Submitted by: Group 4 Questions for Case Discussions VALEANT’S BATTLE FOR ALLERGAN Q.1) Why does Valeant wish to acquire or merge with Allergan? Q2.) What potential value does Valeant believe it can create with the merger with PGP/22/240 MANAV DHIMAN PGP/22/241 AKASH AGRAWAL PGP/22/242 BHAVESH AGRAWAL PGP/22/244 ABHISHEK MODI PGP/22/245 MOHIT KUMAR
Allergan?
Q.3) Is Valeant offering a premium to Allergan’s shareholders for the change of control?

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture